139 related articles for article (PubMed ID: 36802351)
21. Geometric Image Biomarker Changes of the Parotid Gland Are Associated With Late Xerostomia.
van Dijk LV; Brouwer CL; van der Laan HP; Burgerhof JGM; Langendijk JA; Steenbakkers RJHM; Sijtsema NM
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1101-1110. PubMed ID: 28939226
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
Med Phys; 2012 Sep; 39(9):5732-9. PubMed ID: 22957638
[TBL] [Abstract][Full Text] [Related]
23. Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.
Teng F; Fan W; Luo Y; Ju Z; Gong H; Ge R; Tong F; Zhang X; Ma L
Biomed Res Int; 2019; 2019():2401743. PubMed ID: 31380414
[TBL] [Abstract][Full Text] [Related]
24. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
[TBL] [Abstract][Full Text] [Related]
25. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.
Owosho AA; Thor M; Oh JH; Riaz N; Tsai CJ; Rosenberg H; Varthis S; Yom SH; Huryn JM; Lee NY; Deasy JO; Estilo CL
J Craniomaxillofac Surg; 2017 Apr; 45(4):595-600. PubMed ID: 28256385
[TBL] [Abstract][Full Text] [Related]
26. Validation of the
Li Y; Sijtsema NM; de Vette SPM; Steenbakkers RJHM; Zhang F; Noordzij W; Van den Bosch L; Langendijk JA; van Dijk LV
Radiother Oncol; 2023 Mar; 180():109458. PubMed ID: 36608769
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
28. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.
Nardone V; Tini P; Nioche C; Mazzei MA; Carfagno T; Battaglia G; Pastina P; Grassi R; Sebaste L; Pirtoli L
Radiol Med; 2018 Jun; 123(6):415-423. PubMed ID: 29368244
[TBL] [Abstract][Full Text] [Related]
29. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
[TBL] [Abstract][Full Text] [Related]
30. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
31. Regional radiation dose susceptibility within the parotid gland: effects on salivary loss and recovery.
Clark H; Hovan A; Moiseenko V; Thomas S; Wu J; Reinsberg S
Med Phys; 2015 Apr; 42(4):2064-71. PubMed ID: 25832096
[TBL] [Abstract][Full Text] [Related]
32. Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?
Nevens D; Nuyts S
Br J Radiol; 2017 Dec; 90(1080):20170596. PubMed ID: 28972794
[TBL] [Abstract][Full Text] [Related]
33. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer.
Voordeckers M; Everaert H; Tournel K; Verellen D; Baron I; Van Esch G; Vanhove C; Storme G
Strahlenther Onkol; 2008 Aug; 184(8):400-5. PubMed ID: 18956516
[TBL] [Abstract][Full Text] [Related]
35. Preservation of parotid function with uncomplicated conformal radiotherapy.
Maes A; Weltens C; Flamen P; Lambin P; Bogaerts R; Liu X; Baetens J; Hermans R; Van den Bogaert W
Radiother Oncol; 2002 May; 63(2):203-11. PubMed ID: 12063010
[TBL] [Abstract][Full Text] [Related]
36. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.
Moiseenko V; Wu J; Hovan A; Saleh Z; Apte A; Deasy JO; Harrow S; Rabuka C; Muggli A; Thompson A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1108-14. PubMed ID: 21640505
[TBL] [Abstract][Full Text] [Related]
37. Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour.
Kaneko M; Shirato H; Nishioka T; Ohmori K; Takinami S; Arimoto T; Kagei K; Miyasaka K; Nakamura M
Oral Oncol; 1998 Mar; 34(2):140-6. PubMed ID: 9682778
[TBL] [Abstract][Full Text] [Related]
38. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
[TBL] [Abstract][Full Text] [Related]
39. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
40. Level II lymph nodes and radiation-induced xerostomia.
Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
